Biophore India Pharma arm gets CDSCO nod to manufacture, sell generic version of Pfizer COVID drug Paxlovid Ruchika Sharma28 July 2022 12:32 PM ISTIt was the first oral pill that has been approved by USFDA and with a better safety profile than subsequently approved oral therapies.
USFDA authorizes pharmacists to prescribe Pfizer COVID drug Paxlovid Ruchika Sharma8 July 2022 2:30 PM ISTThe agency said patients who tested positive for COVID-19 should bring their health records for the pharmacists to review for kidney and liver...
German health minister in move to boost COVID drug Paxlovid use Ruchika Sharma4 July 2022 12:58 PM ISTThe pill, which won conditional European marketing approval in January, is given to infected people who are at high risk of progression to severe...
Pfizer seeks USFDA nod for COVID drug Paxlovid for high-risk patients Ruchika Sharma2 July 2022 11:55 AM ISTPAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.
Pfizer sued for patent infringement over Paxlovid Roshni Dhar25 Jun 2022 5:30 PM ISTPfizer Inc's blockbuster COVID-19 treatment Paxlovid violates an Enanta Pharmaceuticals Inc patent for its COVID drug still in development, according...
Health Bulletin 25/June/2022 Roshni Dhar25 Jun 2022 4:34 PM ISTHere are the top health stories for the day:Every harm, intimidation, obstruction or hindrance to healthcare professionals is violence: Kerala...
Pfizer sued for patent infringement over COVID-19 drug Paxlovid Ruchika Sharma24 Jun 2022 12:35 PM ISTEnanta requested an unspecified amount of money damages from Pfizer, including royalties.
Pfizer halts COVID drug Paxlovid trial for standard-risk population Ruchika Sharma16 Jun 2022 2:47 PM ISTThe new data, however, showed a 51% relative risk reduction in standard-risk groups, which the company said was not statistically significant.
Study says Pfizer COVID drug Paxlovid reduces COVID risk in seniors regardless of vaccine status Ruchika Sharma3 Jun 2022 1:17 PM ISTPfizer's clinical trial tested Paxlovid in unvaccinated people who had risk factors for serious disease and found that the two-drug treatment cut the...
Generic drugmakers to sell Pfizer COVID drug Paxlovid for USD 25 or less in low-income countries Ruchika Sharma14 May 2022 11:00 AM ISTCHAI said the $25 price ceiling would apply only if there is demand from the poorer countries for at least 1 million treatment courses a year.
Evidence mounts for need to study Pfizer oral antiviral treatment Paxlovid for long COVID: Researchers Ruchika Sharma8 May 2022 10:30 AM ISTPfizer spokesman Kit Longley said company does not have any current long COVID studies underway, but was monitoring data from ongoing clinical studies...
COVID drug makers posting record profits, but treatment out of reach for poor, says WHO MD Bureau8 May 2022 10:00 AM ISTCalling it a "moral failing" Ghebreyesus said that "we cannot accept prices that make life-saving treatments available to the rich and out of reach...
